
Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies
Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their own antibody response, a large British study published on Wednesday found.
The therapy, ...